UA61056U - method for evaluating the effectiveness of treatment with PERINDOPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
- Google Patents
method for evaluating the effectiveness of treatment with PERINDOPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"filedCriticalГосударственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority to UAU201014227UpriorityCriticalpatent/UA61056U/en
Publication of UA61056UpublicationCriticalpatent/UA61056U/en
Investigating Or Analysing Biological Materials
(AREA)
Abstract
A method for evaluating the effectiveness of treatment with perindopril of patients with coronary heart disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type comprises the comparison of patients before and after treatment. According to the method for treatment with perindopril to the patient at rest the Doppler echocardiography is performed and the transmitral blood flow is determined by measuring the rate of early diastolic filling. Further, after treatment with perindopril the similar study is performed.
UAU201014227U2010-11-292010-11-29method for evaluating the effectiveness of treatment with PERINDOPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
UA61056U
(en)
method for evaluating the effectiveness of treatment with PERINDOPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
method for evaluating the effectiveness of treatment with PERINDOPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
method for evaluating the effectiveness of treatment with PERINDOPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
method for evaluating the effectiveness of treatment with PERINDOPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
method for evaluating the effectiveness of treatment with benidipin of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
method for evaluating the effectiveness of treatment with ISRADIPIN of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
method for evaluating the effectiveness of treatment with MANIDIPIN of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
method for evaluating the effectiveness of treatment with quinapril of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
method for evaluating the effectiveness of treatment with MOEXOPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
method for evaluating the effectiveness of treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle by "hypertrophic" type
Method for assesment of effectiveness of treatment WITH CILASAPRIL of patients with coronary artery disease with angina pectoris and hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
method for evaluating the effectiveness of treatment with trimetazidine of patients with ischemic heart disease with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
method for evaluating the effectiveness of treatment with clintiazem of patients with ischemia with angina pectoris and arterial hypertension with diastolic dysfunction of the left ventricle of "hypertrophic" type
Method for assessing efficacy of cilasapril treatment in patients with ischemic heart disease, angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
Method for assessing efficacy of celiprolol treatment in patients with ischemic heart disease, cardiac angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
Method for assessing efficacy of oxprenolol treatment in patients with ischemic heart disease, cardiac angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
Method for assessing efficacy of amlodipin in treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type of impairment of diastolic function of left ventricle
Method for the assessment of acebutolol therapy efficiency in patients with coronary disease with cardiac angina and arterial hypertension with left ventricular hypertrophy
Method for assessing efficacy of felodipine in treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type of impairment of diastolic function of left ventricle
Method for the assessment of labetalol therapy efficiency in patients with coronary disease with cardiac angina and arterial hypertension with left ventricular hypertrophy
method for evaluating of treatment effectiveness of patients with ischemic heart disease and angina pectoris, and hypertension with diastolic impairment of the left ventricle by 'hypertrophy' type
Method for assessment of isosorbit dinitrate efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type
Method for assessing efficacy of lovastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessment of treatment efficacy in patients with ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic type impairment of diastolic function of left ventricle
Method for assessing efficacy of s-amlodipine in treating ischemic heart disease with angina and arterial hypertension with hypertrophic type impairment of diastolic function of left ventricle
Method for the assessment of talinolol therapy efficiency in patients with coronary disease with cardiac angina and hypertensive left ventricular hypertrophy
method for evaluating the effectiveness of treatment with losartan of patients with coronary heart disease with angina pectoris and hypertension at disorder of left ventricular diastolic function by "hypertrophic" type
Method for assessing efficacy of nisoldipine for treatment of ischemic heart disease with angina pectoris and arterial hypertension with hypertrophic-type impairment of diastolic function of left ventricle